Market Overview:
The global mycoplasma plate antigen market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of mycoplasma infections, rising demand for rapid and accurate diagnosis, and technological advancements in diagnostic methods. Based on type, the global mycoplasma plate antigen market is segmented into plate agglutination test products and confirmatory testing reagents. The plate agglutination test products segment is further divided into latex agglutination kits and enzyme-linked immunosorbent assay (ELISA) kits. The confirmatory testing reagents segment includes monoclonal antibodies (MAbs), polyclonal antibodies (PCAs), recombinant proteins, nucleic acid probes, and other confirmatory tests reagents. Based on application, the global mycoplasma plate antigen market is segmented into drug development, infection medicine, veterinary research, and others.
Product Definition:
Mycoplasma Plate antigen is a protein found on the surface of certain strains of mycoplasma. It is used as a diagnostic marker to help identify these strains.
Plate Agglutination Test Products:
Plate agglutination test products, it's usage.
Mycoplasma is a gram-positive bacteria belonging to the class Gammaproteobacteria. It causes respiratory infections and sexually transmitted diseases. The most common cause of mycoplasmosis is M. tuberculosis & M.
Confirmatory Testing Reagents:
Mycoplasma Plate Antigen Market Size, Share & Trends Analysis Report By Product (Reagents, Kits), By Application (Diagnostics Centers, Hospitals), And Segment Forecasts, 2019 - 2025 -> The global confirmatory testing reagents and it's usage in mycoplasma plate antigen market size was valued at USD 81.5 million in 2018.
Application Insights:
The others segment held the largest market share of over 50% in 2017. The application includes research applications, such as drug development and toxicology testing. Mycoplasma antigen tests are used to screen samples for mycoplasma contamination during clinical trials or before starting a new drug development program. These tests also help determine the appropriate study design and selection of control groups to avoid bias in clinical trials caused due to contamination by mycoplasma organisms.
Drug discovery is expected to be one of the fastest-growing segments owing to increasing R&D investments by various companies for discovering novel drugs with better therapeutic potentials against cancer, infectious diseases, autoimmune disorders & cardiovascular diseases etc. However, high cost associated with these types of studies may hinder its growth over the forecast period thereby restricting its market share in other applications segmented into drug development and infection medicine over next eight years (2018-2030).
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biotechnology and pharmaceutical companies, advanced healthcare infrastructure, and high prevalence of chronic diseases are some factors responsible for its largest share. Moreover, increasing demand for animal-derived meat products is expected to increase the use of mycoplasma testing kits in this region.
Asia Pacific is anticipated to grow at a lucrative rate over the forecast period owing to rising investments by government organizations in order to improve healthcare facilities coupled with growing awareness among people about early diagnosis & treatment methods for infectious diseases such as Mycoplasma pneumoniae & M tuberculosis. These aforementioned factors are expected to drive regional growth during the forecast period (2018 - 2030). However, stringent regulations by regulatory agencies such as FDA may hinder market growth during future years due to lack or compliance with cGMP manufacturing standards which would result into lower revenue generation compared with North America and Europe regions (Chen et al., 2016).
Growth Factors:
- Increasing prevalence of Mycoplasma infections: The global incidence of mycoplasma infections is increasing due to the growing population and the increased travel and trade activities. This is expected to drive the demand for mycoplasma plate antigen tests, thereby propelling the growth of the market.
- Rising awareness about mycoplasma infections: There is a growing awareness among people about mycoplasma infections and their symptoms. This is likely to increase the demand for diagnostic tests for these infections, which in turn will boost the growth of Mycoplasma Plate Antigen market.
- Technological advancements in diagnostics: The technological advancements in diagnostics are aiding in early diagnosis of mycoplasma infection cases. This is resulting in an increase in demand for diagnostic tests, thereby driving market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Mycoplasma Plate Antigen Market Research Report
By Type
Plate Agglutination Test Products, Confirmatory Testing Reagents
By Application
Drug Development, Infection Medicine, Veterinary Research, Others
By Companies
Charles River, Prospec-Tany Technogene Ltd, Abnova Corporation, Qiagen N.V., MyBiosource, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Mycoplasma Plate Antigen Market Report Segments:
The global Mycoplasma Plate Antigen market is segmented on the basis of:
Types
Plate Agglutination Test Products, Confirmatory Testing Reagents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Development, Infection Medicine, Veterinary Research, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Charles River
- Prospec-Tany Technogene Ltd
- Abnova Corporation
- Qiagen N.V.
- MyBiosource, Inc.
Highlights of The Mycoplasma Plate Antigen Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Plate Agglutination Test Products
- Confirmatory Testing Reagents
- By Application:
- Drug Development
- Infection Medicine
- Veterinary Research
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mycoplasma Plate Antigen Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mycoplasma Plate Antigen is a protein that helps to identify Mycoplasma bacteria.
Some of the major companies in the mycoplasma plate antigen market are Charles River, Prospec-Tany Technogene Ltd, Abnova Corporation, Qiagen N.V., MyBiosource, Inc..
The mycoplasma plate antigen market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Mycoplasma Plate Antigen Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Mycoplasma Plate Antigen Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Mycoplasma Plate Antigen Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Mycoplasma Plate Antigen Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Mycoplasma Plate Antigen Market Size & Forecast, 2018-2028
4.5.1 Mycoplasma Plate Antigen Market Size and Y-o-Y Growth
4.5.2 Mycoplasma Plate Antigen Market Absolute $ Opportunity
Chapter 5 Global Mycoplasma Plate Antigen Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Mycoplasma Plate Antigen Market Size Forecast by Type
5.2.1 Plate Agglutination Test Products
5.2.2 Confirmatory Testing Reagents
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Mycoplasma Plate Antigen Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Mycoplasma Plate Antigen Market Size Forecast by Applications
6.2.1 Drug Development
6.2.2 Infection Medicine
6.2.3 Veterinary Research
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Mycoplasma Plate Antigen Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Mycoplasma Plate Antigen Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Mycoplasma Plate Antigen Analysis and Forecast
9.1 Introduction
9.2 North America Mycoplasma Plate Antigen Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Mycoplasma Plate Antigen Market Size Forecast by Type
9.6.1 Plate Agglutination Test Products
9.6.2 Confirmatory Testing Reagents
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Mycoplasma Plate Antigen Market Size Forecast by Applications
9.10.1 Drug Development
9.10.2 Infection Medicine
9.10.3 Veterinary Research
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Mycoplasma Plate Antigen Analysis and Forecast
10.1 Introduction
10.2 Europe Mycoplasma Plate Antigen Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Mycoplasma Plate Antigen Market Size Forecast by Type
10.6.1 Plate Agglutination Test Products
10.6.2 Confirmatory Testing Reagents
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Mycoplasma Plate Antigen Market Size Forecast by Applications
10.10.1 Drug Development
10.10.2 Infection Medicine
10.10.3 Veterinary Research
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Mycoplasma Plate Antigen Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Mycoplasma Plate Antigen Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Mycoplasma Plate Antigen Market Size Forecast by Type
11.6.1 Plate Agglutination Test Products
11.6.2 Confirmatory Testing Reagents
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Mycoplasma Plate Antigen Market Size Forecast by Applications
11.10.1 Drug Development
11.10.2 Infection Medicine
11.10.3 Veterinary Research
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Mycoplasma Plate Antigen Analysis and Forecast
12.1 Introduction
12.2 Latin America Mycoplasma Plate Antigen Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Mycoplasma Plate Antigen Market Size Forecast by Type
12.6.1 Plate Agglutination Test Products
12.6.2 Confirmatory Testing Reagents
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Mycoplasma Plate Antigen Market Size Forecast by Applications
12.10.1 Drug Development
12.10.2 Infection Medicine
12.10.3 Veterinary Research
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Mycoplasma Plate Antigen Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Mycoplasma Plate Antigen Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Mycoplasma Plate Antigen Market Size Forecast by Type
13.6.1 Plate Agglutination Test Products
13.6.2 Confirmatory Testing Reagents
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Mycoplasma Plate Antigen Market Size Forecast by Applications
13.10.1 Drug Development
13.10.2 Infection Medicine
13.10.3 Veterinary Research
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Mycoplasma Plate Antigen Market: Competitive Dashboard
14.2 Global Mycoplasma Plate Antigen Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Charles River
14.3.2 Prospec-Tany Technogene Ltd
14.3.3 Abnova Corporation
14.3.4 Qiagen N.V.
14.3.5 MyBiosource, Inc.
